2024-12-01 - Analysis Report
## Eli Lilly and Co (LLY) Stock Report

**1. Performance Comparison & Divergence:**

Eli Lilly and Co. (LLY) is a pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.

LLY's cumulative return is significantly higher than the S&P 500 (VOO).  The difference in cumulative returns between LLY and VOO is 501.0 percentage points (631.05 - 130.06 = 501). This places LLY at the 74.4th percentile of its historical performance relative to the S&P 500 based on the provided data.  The provided CAGR data shows consistently strong performance significantly outpacing the S&P 500 over the provided timeframes, with alpha consistently near zero suggesting that the outperformance is not due to idiosyncratic factors. The Beta values suggest a high sensitivity to market movements.

**2. Recent Price Movement:**

* **Closing Price:** $795.35
* **5-Day Moving Average:** $775.17
* **20-Day Moving Average:** $782.74
* **60-Day Moving Average:** $863.23

The price is below all three moving averages, suggesting a potential short-term bearish trend.  The significant difference between the closing price and the 60-day moving average indicates a substantial price drop from recent highs. The Last-market price of 796.29 is not significantly different from the closing price, indicating no major price swings within a single trading day.


**3. Technical Indicators & Expected Return:**

* **RSI:** 40.64 (Below 50, suggesting oversold conditions)
* **PPO:** 0.74 (Positive, indicating bullish momentum, but relatively low)
* **20-Day Relative Divergence:**  NaN (-), indicating a recent short-term downtrend.
* **Expected Return (2+ years):** 573.4% (This represents a significant outperformance expectation relative to the S&P 500 over the long term.  This figure must be treated with caution as it depends on multiple assumptions and past performance is not indicative of future results.)

The combination of a low RSI and negative recent relative divergence suggests that despite the positive PPO, the stock might be experiencing a short-term pullback. The high expected return highlights the potential for strong long-term growth, but it's crucial to acknowledge the inherent risks associated with long-term projections.


**4. Recent Earnings Analysis:**

The provided earnings data shows significant volatility in EPS and relatively stable revenue growth.

* **Revenue Growth:** Revenue has been relatively stable in the recent past, fluctuating around the $9-11B range, except for a dip in Q1 2024.
* **EPS Trends:** EPS shows significant variation, with a large positive value in Q2 2024 followed by a less positive value in Q3 2024 and negative values in Q4 2023 and what appears to be a duplicate entry for Q4 2023.
* **Notable Changes:** The large drop in EPS from Q2 2024 to Q3 2024 warrants further investigation. The negative EPS in two quarters within a year also necessitates additional analysis beyond the scope of the provided data.  There is no information provided for comparisons to analysts' expectations, therefore beats or misses cannot be determined.

**5. Financial Information Analysis:**

* **Revenue and Profitability:**  Revenue is relatively stable, showing minor fluctuations throughout the periods. Profit margins remain consistently high (above 80%), indicating strong profitability.
* **Capital and Profitability:** Equity has shown an increasing trend.  ROE, however, is highly volatile, ranging from a negative value to over 20% within a short period, highlighting potential fluctuations in profitability and return on investment.

**6. News and Recent Issues:**

No recent news (within the last two days) is provided.  Therefore, there is no information on recent market outlook or analyst opinions.

**7. Overall Analysis:**

LLY has demonstrated exceptionally strong performance relative to the S&P 500, based on the cumulative return figures provided. However, recent price action suggests a potential short-term bearish trend, despite the high expected return projection.  Earnings reports show considerable variability in EPS and relatively stable revenue. The financial information indicates high profitability, but the substantial fluctuation in ROE raises concerns regarding consistency.  The absence of recent news and analyst opinions limits a more comprehensive analysis.  Further investigation into the significant EPS variations, the discrepancy in the Q4 2023 data entry, and the inclusion of recent news and analyst sentiment is needed to provide a more complete assessment.

**8. Disclaimer:**  This report is based solely on the data provided. It does not constitute financial advice. Investment decisions should be made after conducting thorough independent research and considering your personal risk tolerance.  Past performance is not indicative of future results.  Missing data and lack of contextual information limit the conclusiveness of this analysis.
